Einstein Experts for Media

Search Results

You searched for "Type 1 diabetes"

3 results found

Norman Fleischer, M.D.

Norman Fleischer, M.D.

Professor, Medicine (Endocrinology), Einstein

Jacob A. and Jeanne E. Barkey Chair in Medicine, Einstein

Co-Director, Diabetes Research Center, Einstein

Chief, Endocrinology, Department of Medicine, Einstein and Montefiore Health System

EndocrinologyType 1 diabetes

Dr. Fleischer is a nationally recognized authority in diabetes treatment and research, with more than four decades of experience in the field. In the 1970s, he founded the NIH-funded Einstein’s Diabetes Research Center, which was among the first NIH-supported diabetes centers in the country. Today, it is one of only two such Centers in New York and one of only a dozen nationwide. read more...


Jeffrey E. Pessin, Ph.D.

Jeffrey E. Pessin, Ph.D.

Professor, Medicine (Endocrinology)

Professor, Molecular Pharmacology

Director, Einstein-Mount Sinai Diabetes Research Center

Judy R. and Alfred A. Rosenberg Professorial Chair in Diabetes Research

DiabetesType 1 diabetesMetabolism

Dr. Pessin directs the Einstein-Mount Sinai Diabetes Research Center, one of only sixteen NIH-funded diabetes centers of its kind in the country. He guides the research of more than 90 scientists investigating type 1 (formerly juvenile) and type 2 (formerly adult-onset) diabetes. The center also includes training programs and community-based activities in the Bronx. Dr. Pessin’s own research focuses on insulin signaling and the mechanisms contributing to the onset of type 1 diabetes. read more...


Joel Zonszein, M.D.

Joel Zonszein, M.D.

Professor, Clinical Medicine (Endocrinology), Einstein

Director, Clinical Diabetes Center, Montefiore Health System

Diabetes (clinical)Type 1 diabetesType 2 diabetes

Diabetes preventionCardiovascular disease

Dr. Zonszein is an experienced clinician and researcher who focuses on preventing and treating types 1 and 2 diabetes. He has participated in landmark NIH studies, including the Diabetes Control and Complications Trial and the Diabetes Prevention Program. He has a special interest in understanding cardiovascular disease in people with diabetes and serves as the principal investigator of an ongoing NIH-sponsored study to find the best way to manage coronary artery disease in patients with type 2 diabetes.  read more...